Industry Research Reports
Home > Reports > Chemical & Material > Dutasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Dutasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 128 Pages
Report ld: 3959953
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Dutasteride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
North American market for Dutasteride API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dutasteride API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Dutasteride API was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Dutasteride API include Dr. Reddy’s Laboratories Ltd., Gonane Pharma, Sterling Spa, Stermone Chemicals, Hubei Gedian Humanwell Pharmaceutical Co.,Ltd., Gador SA, Cipla, Zhejiang Xianju Junye Pharmaceutical Co., Ltd., Aspen Biopharma Labs, Chongqing Huapont Pharmaceutical, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Dutasteride API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dutasteride API by region & country, by Type, and by Application.
The Dutasteride API market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dutasteride API.
MARKET SEGMENTATION
By Company
- Dr. Reddy’s Laboratories Ltd.
- Gonane Pharma
- Sterling Spa
- Stermone Chemicals
- Hubei Gedian Humanwell Pharmaceutical Co.,Ltd.
- Gador SA
- Cipla
- Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
- Aspen Biopharma Labs
- Chongqing Huapont Pharmaceutical
- Swati Spentose Pvt.Ltd.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity≥98%
- Purity<98%
Segment by Application
- Dutasteride Tablets
- Dutasteride Capsules
- Others
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Dutasteride API Product Introduction
1.2 Global Dutasteride API Market Size Forecast
1.2.1 Global Dutasteride API Sales Value (2020-2031)
1.2.2 Global Dutasteride API Sales Volume (2020-2031)
1.2.3 Global Dutasteride API Sales Price (2020-2031)
1.3 Dutasteride API Market Trends & Drivers
1.3.1 Dutasteride API Industry Trends
1.3.2 Dutasteride API Market Drivers & Opportunity
1.3.3 Dutasteride API Market Challenges
1.3.4 Dutasteride API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dutasteride API Players Revenue Ranking (2024)
2.2 Global Dutasteride API Revenue by Company (2020-2025)
2.3 Global Dutasteride API Players Sales Volume Ranking (2024)
2.4 Global Dutasteride API Sales Volume by Company Players (2020-2025)
2.5 Global Dutasteride API Average Price by Company (2020-2025)
2.6 Key Manufacturers Dutasteride API Manufacturing Base and Headquarters
2.7 Key Manufacturers Dutasteride API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dutasteride API
2.9 Dutasteride API Market Competitive Analysis
2.9.1 Dutasteride API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Dutasteride API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dutasteride API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity≥98%
3.1.2 Purity
TABLE OF FIGURES
List of Tables
Table 1. Dutasteride API Market Trends
Table 2. Dutasteride API Market Drivers & Opportunity
Table 3. Dutasteride API Market Challenges
Table 4. Dutasteride API Market Restraints
Table 5. Global Dutasteride API Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Dutasteride API Revenue Market Share by Company (2020-2025)
Table 7. Global Dutasteride API Sales Volume by Company (2020-2025) & (Ton)
Table 8. Global Dutasteride API Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Dutasteride API Price by Company (2020-2025) & (US$/Ton)
Table 10. Key Manufacturers Dutasteride API Manufacturing Base and Headquarters
Table 11. Key Manufacturers Dutasteride API Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Dutasteride API
Table 13. Global Dutasteride API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dutasteride API as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Dutasteride API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Dutasteride API Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Dutasteride API Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Dutasteride API Sales Market Share in Value by Type (2020-2025)
Table 20. Global Dutasteride API Sales Market Share in Value by Type (2026-2031)
Table 21. Global Dutasteride API Sales Volume by Type: 2020 VS 2024 VS 2031 (Ton)
Table 22. Global Dutasteride API Sales Volume by Type (2020-2025) & (Ton)
Table 23. Global Dutasteride API Sales Volume by Type (2026-2031) & (Ton)
Table 24. Global Dutasteride API Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Dutasteride API Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Dutasteride API Price by Type (2020-2025) & (US$/Ton)
Table 27. Global Dutasteride API Price by Type (2026-2031) & (US$/Ton)
Table 28. Global Dutasteride API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Dutasteride API Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Dutasteride API Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Dutasteride API Sales Market Share in Value by Application (2020-2025)
Table 32. Global Dutasteride API Sales Market Share in Value by Application (2026-2031)
Table 33. Global Dutasteride API Sales Volume by Application: 2020 VS 2024 VS 2031 (Ton)
Table 34. Global Dutasteride API Sales Volume by Application (2020-2025) & (Ton)
Table 35. Global Dutasteride API Sales Volume by Application (2026-2031) & (Ton)
Table 36. Global Dutasteride API Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Dutasteride API Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Dutasteride API Price by Application (2020-2025) & (US$/Ton)
Table 39. Global Dutasteride API Price by Application (2026-2031) & (US$/Ton)
Table 40. Global Dutasteride API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Dutasteride API Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Dutasteride API Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Dutasteride API Sales Value by Region (2020-2025) & (%)
Table 44. Global Dutasteride API Sales Value by Region (2026-2031) & (%)
Table 45. Global Dutasteride API Sales Volume by Region (Ton): 2020 VS 2024 VS 2031
Table 46. Global Dutasteride API Sales Volume by Region (2020-2025) & (Ton)
Table 47. Global Dutasteride API Sales Volume by Region (2026-2031) & (Ton)
Table 48. Global Dutasteride API Sales Volume by Region (2020-2025) & (%)
Table 49. Global Dutasteride API Sales Volume by Region (2026-2031) & (%)
Table 50. Global Dutasteride API Average Price by Region (2020-2025) & (US$/Ton)
Table 51. Global Dutasteride API Average Price by Region (2026-2031) & (US$/Ton)
Table 52. Key Countries/Regions Dutasteride API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Dutasteride API Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Dutasteride API Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Dutasteride API Sales Volume, (2020-2025) & (Ton)
Table 56. Key Countries/Regions Dutasteride API Sales Volume, (2026-2031) & (Ton)
Table 57. Dr. Reddy’s Laboratories Ltd. Company Information
Table 58. Dr. Reddy’s Laboratories Ltd. Introduction and Business Overview
Table 59. Dr. Reddy’s Laboratories Ltd. Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 60. Dr. Reddy’s Laboratories Ltd. Dutasteride API Product Offerings
Table 61. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 62. Gonane Pharma Company Information
Table 63. Gonane Pharma Introduction and Business Overview
Table 64. Gonane Pharma Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 65. Gonane Pharma Dutasteride API Product Offerings
Table 66. Gonane Pharma Recent Development
Table 67. Sterling Spa Company Information
Table 68. Sterling Spa Introduction and Business Overview
Table 69. Sterling Spa Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 70. Sterling Spa Dutasteride API Product Offerings
Table 71. Sterling Spa Recent Development
Table 72. Stermone Chemicals Company Information
Table 73. Stermone Chemicals Introduction and Business Overview
Table 74. Stermone Chemicals Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Stermone Chemicals Dutasteride API Product Offerings
Table 76. Stermone Chemicals Recent Development
Table 77. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Company Information
Table 78. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Introduction and Business Overview
Table 79. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Dutasteride API Product Offerings
Table 81. Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Recent Development
Table 82. Gador SA Company Information
Table 83. Gador SA Introduction and Business Overview
Table 84. Gador SA Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Gador SA Dutasteride API Product Offerings
Table 86. Gador SA Recent Development
Table 87. Cipla Company Information
Table 88. Cipla Introduction and Business Overview
Table 89. Cipla Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Cipla Dutasteride API Product Offerings
Table 91. Cipla Recent Development
Table 92. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Company Information
Table 93. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 94. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Dutasteride API Product Offerings
Table 96. Zhejiang Xianju Junye Pharmaceutical Co., Ltd. Recent Development
Table 97. Aspen Biopharma Labs Company Information
Table 98. Aspen Biopharma Labs Introduction and Business Overview
Table 99. Aspen Biopharma Labs Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Aspen Biopharma Labs Dutasteride API Product Offerings
Table 101. Aspen Biopharma Labs Recent Development
Table 102. Chongqing Huapont Pharmaceutical Company Information
Table 103. Chongqing Huapont Pharmaceutical Introduction and Business Overview
Table 104. Chongqing Huapont Pharmaceutical Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Chongqing Huapont Pharmaceutical Dutasteride API Product Offerings
Table 106. Chongqing Huapont Pharmaceutical Recent Development
Table 107. Swati Spentose Pvt.Ltd. Company Information
Table 108. Swati Spentose Pvt.Ltd. Introduction and Business Overview
Table 109. Swati Spentose Pvt.Ltd. Dutasteride API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Swati Spentose Pvt.Ltd. Dutasteride API Product Offerings
Table 111. Swati Spentose Pvt.Ltd. Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Dutasteride API Downstream Customers
Table 115. Dutasteride API Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Dutasteride API Product Picture
Figure 2. Global Dutasteride API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Dutasteride API Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Dutasteride API Sales Volume (2020-2031) & (Ton)
Figure 5. Global Dutasteride API Sales Price (2020-2031) & (US$/Ton)
Figure 6. Dutasteride API Report Years Considered
Figure 7. Global Dutasteride API Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Dutasteride API Players Sales Volume Ranking (2024) & (Ton)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dutasteride API Revenue in 2024
Figure 10. Dutasteride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Purity≥98% Picture
Figure 12. Purity
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Dutasteride API market?
The top companies in the global Dutasteride API market are Dr. Reddy’s Laboratories Ltd.、Gonane Pharma、Sterling Spa.
Related Reports
Dutasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dutasteride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 145
USD 3950.00
(Single User License)
Global Dutasteride API Market Research Report 2026
The global Dutasteride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 144
USD 2900.00
(Single User License)
Global Dutasteride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dutasteride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 155
USD 4900.00
(Single User License)
Global Dutasteride API Market Research Report 2025
The global market for Dutasteride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 96
USD 2900.00
(Single User License)
Global Dutasteride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dutasteride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 96
USD 4250.00
(Single User License)
Global Dutasteride API Market Insights, Forecast to 2030
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Published Date: 2024-04-15
Pages: 112
USD 4900.00
(Single User License)
Dutasteride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Published Date: 2024-02-23
Pages: 125
USD 3950.00
(Single User License)
Global Dutasteride API Market Research Report 2024
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Published Date: 2024-01-10
Pages: 103
USD 2900.00
(Single User License)
Dutasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dutasteride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 145
USD 3950.00 (Single User License)Global Dutasteride API Market Research Report 2026
The global Dutasteride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 144
USD 2900.00 (Single User License)Global Dutasteride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dutasteride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 155
USD 4900.00 (Single User License)Global Dutasteride API Market Research Report 2025
The global market for Dutasteride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 96
USD 2900.00 (Single User License)Global Dutasteride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dutasteride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 96
USD 4250.00 (Single User License)Global Dutasteride API Market Insights, Forecast to 2030
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Published: 2024-04-15
Pages: 112
USD 4900.00 (Single User License)Dutasteride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Published: 2024-02-23
Pages: 125
USD 3950.00 (Single User License)Global Dutasteride API Market Research Report 2024
Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
Published: 2024-01-10
Pages: 103
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now